The Benefits of Coronary CTA in Pharmaceutical Clinical Trials
Coronary computed tomography angiography is a cheaper, less-invasive alternative to intravascular ultrasound in pharmaceutical clinical trials
Source: itnonline.com
📰 Plaque Progression News
Plaque Progression News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Plaque Progression. Real-time updates on events, politics, business and more.
The Benefits of Coronary CTA in Pharmaceutical Clinical Trials
Coronary computed tomography angiography is a cheaper, less-invasive alternative to intravascular ultrasound in pharmaceutical clinical trials
Source: dicardiology.com
Amarin Corporation plc: Amarin Highlights New Data Providing Potential Mechanistic Insight into Vascepa®/Vazkepa® (Icosapent Ethyl) Reduction of Cardiovascular Events
- New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression - --Data Further Advances Understanding of VASCEPA/VAZKEPA Potential Mechanism
Source: finanznachrichten.de
Amarin Highlights New Data Providing Potential Mechanistic Insight into Vascepa®/Vazkepa® (Icosapent Ethyl) Reduction of Cardiovascular Events
— New Research Demonstrates Multifactorial Beneficial Effects of VASCEPA/VAZKEPA on Coronary Physiology and Plaque Progression — --Data Further Advances Understanding of VASCEPA/VAZKEPA... | May 12, 2023
Source: marketscreener.com